New Mexico Register / Volume XXXV, Issue 19 / October 8, 2024

This is an amendment to 16.22.22 NMAC, Section 8, effective 10/08/2024.

16.22.22.8 PSYCHOPHARMACOLOGY (RxP) APPLICATION COMMITTEE:

A. The chair of the board may appoint one or more RxP application committee(s) to review application(s) for conditional prescription and prescription certificates and to make recommendations to the board.

B. The RxP application committee will consist of a minimum of three members who shall reside in New Mexico and who shall hold active, unrestricted New Mexico licenses in their respective profession. The committee shall consist of:

(1) one person appointed by the chair of the board who is experienced in psychopharmacology;

(2) one person appointed by the chair of the board, in collaboration with the New Mexico medical board, who is an allopathic or osteopathic physician or a nurse practitioner or physicians assistant with clinical experience in mental health or psychopharmacology [and].

[(3) a public member appointed by the chair of the board.

C. The professional members appointed by the chair of the board to the committee may include:

(1) a psychologist with a conditional prescribing certificate or a prescription certificate;

(2) a physician or osteopathic physician with clinical experience in mental health or psychopharmacology;

(3) a pharmacist clinician, or certified, or certified nurse practitioner, RNCS or physician’s assistant with specialized training in psychopharmacology; or

(4) a licensed psychologist.]

[D.] C. Members of the RxP application committee shall not be in a psychopharmacology training program, and shall not be seeking licensure as a psychologist.

[E.] D. Members of the RxP application committee shall not participate in the review, deliberation, or decision of an application if the applicant is a member of the member’s family or household or if the member has a conflict of interest as defined in 16.22.25 NMAC, of these regulations.

[F.] E. The New Mexico medical board or its designee shall be available upon request to consult with the RxP application committee or the board regarding the applicability of the regulations adopted pursuant to Section 61-9-17.1 NMSA 1978 of the act to a particular application.

[G.] F. The RxP application committee shall provide the board a recommendation to accept or reject an application for a conditional prescription or prescription certificate. A recommendation to reject an application shall state the reasons for the recommendation.

[16.22.22.8 NMAC - Rp, 16.22.22.8 NMAC, 11/15/2006; A, 10/08/2024]